Revenue Estimates Analysis Of Cogentix Medical, Inc. (CGNT)

Marco Green
March 13, 2018

(NASDAQ:CGNT), 0 rate it "Buy", 3 "Outperform", 0 "Underperform", 0 "Sell", while 0 "Hold". However the company reported $0.01 earnings per share for the same quarter during past year.

The shares rose after the company announced that it has entered into a definitive merger agreement, under which Laborie Medical Technologies will acquire all of the outstanding shares of Cogentix Medical for a total consideration of approximately $239 million.

The biggest institutional shareholders in Cogentix Medical, Inc. include Nantahala Capital Management, LLC which owns 4 million shares in the company valued at $9.32 million.

For the full year, analysts anticipate top line of $ 56.20 million, while looking forward to loss of $ 0.01 per share bottom line.

When it comes to the Analysis of a Stock, Price Target plays a vital role. The stock exchanged hands 3.97 Million shares versus average trading capacity of 65.65 Million shares, yielding a market cap of $236.11 Million. The Stock now has a Weekly Volatility of 5.03% and Monthly Volatility of 5.27%. The company posted an earnings surprise of 100%.

At the moment 3 analysts are watching Cogentix Medical, Inc.

In case of Revenue Estimates, 3 analysts have provided their consensus Average Revenue Estimates for Cogentix Medical, 15.33 Million.

Now insiders hold 30,819,372 shares in the business which makes up 50.60% of shares. The stock hit its 52-week high on 03/12/18, and 52-week low on 05/17/17.

Cogentix Medical In (NASDAQ:CGNT)'s trailing twelve month revenues are $54 Million, whereas its price to sales ratio for the same period is 4.37. While it's Return on Investment (ROI) value is -3.1%. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.

Other reports by Click Lancashire

Discuss This Article